Haczku, A <br/><br/>
Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  May 1999 
 - 1638-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/ajrccm.159.5.9711040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--therapeutic use<br/>Antibody Formation--drug effects<br/>Antigens, CD--immunology<br/>B7-2 Antigen<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>Cytokines--analysis<br/>Electric Stimulation<br/>Eosinophilia--drug therapy<br/>Female<br/>Hypersensitivity--complications<br/>Immunoglobulin E--analysis<br/>Immunoglobulin G--analysis<br/>Lung--pathology<br/>Membrane Glycoproteins--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Muscle, Smooth--physiopathology<br/>Ovalbumin--pharmacology<br/>Respiratory Hypersensitivity--blood<br/>Trachea--physiopathology